COQ8B nephropathy: Early detection and optimal treatment. Issue 8 (16th June 2020)

• Record Type: Journal Article
• Authors: Song, Xiaoxiang; Fang, Xiaoyan; Tang, Xiaoshan; Cao, Qi; Zhai, Yihui; Chen, Jing; Liu, Jialu; Zhang, Zhiqing; Xiang, Tianchao; Qian, Yanyan; Wu, Bingbing; Wang, Huijun; Zhou, Wenhao; Liu, Cuihua; Shen, Qian; Xu, Hong; Rao, Jia
• Is Part Of: Molecular genetics & genomic medicine. Volume 8:Issue 8(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2020-06-16
• Subjects: CoQ10 -- COQ8B -- proteinuria -- steroid resistant nephrotic syndrome (SRNS) -- transplantation; Medical genetics -- Periodicals; Genomics -- Periodicals; 616.042
• DOI: 10.1002/mgg3.1360
• Languages: English
• ISSNs: 2324-9269

Abstract

Abstract: Background: Mutations in COQ8B (*615567) as a defect of coenzyme Q10 (CoQ10) cause steroid resistant nephrotic syndrome (SRNS). Methods: To define the clinical course and prognosis of COQ8B nephropathy, we retrospectively assessed the genotype and phenotype in patients with COQ8B mutations from Chinese Children Genetic Kidney Disease Database. We performed the comparing study of renal outcome following CoQ10 treatment and renal transplantation between early genetic detection and delayed genetic detection group. Results: We identified 20 (5.8%) patients with biallelic mutations of COQ8B screening for patients with SRNS, non‐nephrotic proteinuria, or chronic kidney disease (CKD) of unknown origin. Patients with COQ8B mutations showed a largely renal‐limited phenotype presenting with proteinuria and/or advanced CKD at the time of diagnosis. Renal biopsy uniformly showed focal segmental glomerulosclerosis. Proteinuria was decreased, whereas the renal function was preserved in five patients following CoQ10 administration combined with angiotensin‐converting enzyme (ACE) inhibitor. The renal survival analysis disclosed a significantly better outcome in early genetic detection group than in delayed genetic detection group (Kaplan–Meier plot and log rank test, p = .037). Seven patients underwent deceased donor renal transplantation without recurrence of proteinuria or graft failure. Blood pressure showed decreased significantly during 6 to 12 months post transplantation. Conclusions: COQ8B mutations are one of the most common causes of adolescent‐onset proteinuria and/or CKD of unknown etiology in the Chinese children. Early detection of COQ8B nephropathy following CoQ10 supplementation combined with ACE inhibitor could slow the progression of renal dysfunction. Renal transplantation in patients with COQ8B nephropathy showed no recurrence of proteinuria. Abstract : Renal outcome in COQ8B nephropathy.